GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Price-to-Tangible-Book

Benevolent AI (Benevolent AI) Price-to-Tangible-Book : 0.97 (As of May. 28, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Price-to-Tangible-Book?

As of today (2024-05-28), Benevolent AI's share price is $0.70. Benevolent AI's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.72. Hence, Benevolent AI's Price to Tangible Book Ratio of today is 0.97.

The historical rank and industry rank for Benevolent AI's Price-to-Tangible-Book or its related term are showing as below:

BAIVF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.87   Med: 2.22   Max: 2.8
Current: 0.88

During the past 6 years, Benevolent AI's highest Price to Tangible Book Ratio was 2.80. The lowest was 0.87. And the median was 2.22.

BAIVF's Price-to-Tangible-Book is ranked better than
86.57% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs BAIVF: 0.88

A closely related ratio is called PB Ratio. As of today, Benevolent AI's share price is $0.70. Benevolent AI's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.96. Hence, Benevolent AI's P/B Ratio of today is 0.73.


Benevolent AI Price-to-Tangible-Book Historical Data

The historical data trend for Benevolent AI's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Price-to-Tangible-Book Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - - - - 0.78

Benevolent AI Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only - - - - 0.78

Competitive Comparison of Benevolent AI's Price-to-Tangible-Book

For the Biotechnology subindustry, Benevolent AI's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Benevolent AI's Price-to-Tangible-Book falls into.



Benevolent AI Price-to-Tangible-Book Calculation

Benevolent AI's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.70/0.72
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Benevolent AI Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI (Benevolent AI) Business Description

Comparable Companies
Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.